Medicare Proposes to Sharply Limit Coverage of the Alzheimer ’s Drug Aduhelm

If the preliminary decision is finalized this spring, it would restrict coverage to patients in randomized clinical trials.

Source: NYT Health - January 12, 2022 Category: Consumer Health News Authors: Pam Belluck Tags: Drugs (Pharmaceuticals) Aduhelm (Drug) Elderly Alzheimer ' s Disease Medicare Centers for Medicare and Medicaid Services Biogen Inc your-feed-healthcare Source Type: news